http://www.fpnotebook.com/
GalantamineAka: Reminyl, Razadyne
- See Also
- Rivastigmine (Exelon)
- Donepezil (Aricept)
- Indication
- Alzheimer's Disease related Dementia
- Mechanism
- Acetylcholinesterase inhibitor
- Acts also at nicotinic receptors
- Derived from Daffodil bulbs
- Pharmacokinetics
- Half-Life: 7 hours in elderly patients
- Metabolized by liver enzymes: CYP2D6 and CYP3A4
- Dosing
- Initial: 4 mg PO bid with breakfast and dinner x4 weeks
- Maintenance: 8 mg PO bid for at least 4 weeks
- Consider 12 mg PO bid if indicated
- May require concurrent Antiemetic use
- Adverse Effects
- No hepatic toxicity found (contrast with Tacrine)
- Gastrointestinal effects
- Nausea or Vomiting
- Diarrhea
- Anorexia
- Weight loss
- Cardiovascular effects
- Dizziness
- Bradycardia
- Efficacy
- Moderately preserved cognitive function for >6 months
- References
- Raskind (2000) Neurology 54:2261
- Tariot (2000) Neurology 54:2269
- Cost
- (2003) Red Book: $134/month
- References
- (2001) Med Lett Drugs Ther 43(1107):53
|
|---|
| Definition (MSH) | A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. |
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Galantamin, Galantamine, GALANTAMINE PREPARATION, Galanthamine, Lycoremine |
| Spanish | galantamina |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Definition (MSH) | Name of the FDA approved preparation from J&J. |
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Reminyl |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree